Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity

Abstract excerpt

Lafora disease (LD) is a fatal adolescence-onset neurodegenerative condition. The hallmark of LD is the accumulation of aberrant glycogen aggregates called Lafora bodies (LBs) in the brain and other tissues. Impeding glycogen synthesis from early embryonic stages by genetic suppression of glycogen synthase (MGS) in an animal model of LD prevents LB formation and ultimately the pathological manifestations of LD...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Glycogen Storage Diseases and Myoclonus
• Share to Lysosomal Storage Disorders Research
• Share to Protein Tyrosine Phosphatases